The Beijing-based venture capital firm will use the fund to invest in China-based IT companies.
The Edinburgh-based firm is awaiting approval from the FSA to market its first private equity fund, but will soon start doing early stage deals from its newly established angel syndicate arm.
The Finnish alternatives group has so far garnered €203m for its ninth buyout fund.
Björk has lent her name to a fund which will try to stimulate her nation’s stricken economy by investing in local businesses. The fund will be managed by female-centric financial services firm Audur.
Switzerland-based alternative asset manager Finvest Asset Management has launched its first private equity-specific fund to target opportunities arising from the downturn.
Celtic Therapeutics, based in the Virgin Islands, will seek to exploit a ‘crisis’ in the pharmaceutical industry by buying early-to mid-stage drug development programmes. The fund is the successor to Celtic Pharmaceuticals, which reached $400m in commitments and mezzanine funding for investment in drug development programmes.
The firm will also cut management fees across the board and has promised not to call more than 30% of LPs’ total commitment next year.
The UK buyout market has seen deal flow drop 40% in the fourth quarter, according to recent data.
The package reportedly includes subsidies of up to CNY 5m for private equity firms and will be launched before the end of the year.
The private equity unit of Middle East bank Emirates NBD is targeting $500m for its MENASA-focused fund.